跳至主要内容
临床试验/CTRI/2009/091/000702
CTRI/2009/091/000702已完成2 期

A clinical study of a herbal formulation 'Diabeat' as an adjuvant drug for the control of type 2 diabetes mellitus

Hamdard National Foundation New DElhi0 个研究点目标入组 50 人开始时间: 待定最近更新:

试验速览

阶段
2 期
状态
已完成
发起方
入组人数
50

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • 1. Patients of type-2 diabetes mellitus, age 30-60 years taking Metformin for more than 3 months with uncontrolled hyperglycaemia i.e.HbA1C between 7% to 9% and Body Mass Index (BMI) between 25-29.9 kg/m2.
  • 2. Patients who are able and willing to follow anti-diabetic therapy under a stable life style and diabetic diet.
  • 3.Patients who are willing and able to understand and follow the protocol and provide informed consent.

排除标准

  • 1.History of treatment with any insulin
  • 2.Diabetes mellitus with complications
  • 3.Pregnant or Lactating women
  • 4.Women of childbearing potential who do not take adequate contraceptive protection.
  • 5.History of hypersensitivity to the Metformin or to drug with similar chemical structure.
  • 6.History of any severe systemic disease.
  • 7.Patients with uncontrolled hypertension.
  • 8.History of drug or alcohol abuse.

研究者

发起方
Hamdard National Foundation New DElhi

相似试验